Global Medical Device Packaging Market to be Worth USD 65.26 Billion by 2033: Future Market Insights, Inc.

The global medical device packaging market is expected to be worth USD 38.57 billion in 2023, rising to USD 65.26 billion by 2033. The adoption of medical device packaging is expected to surge at a stable CAGR of 6.1% over the forecast period.

The medical device packaging market is experiencing significant growth driven by several key factors. The increasing aging population and the associated rise in chronic diseases are driving the demand for medical devices such as pacemakers, stents, and artificial joints, leading to an increased need for proper packaging to ensure the safety and integrity of these devices.

Advancements in medical technology have also led to the development of new medical devices, requiring manufacturers to invest in packaging solutions to protect them during transportation and storage.

Discover the Full Details in Our Report—Read More Now!

In addition, the growing demand for minimally invasive surgical procedures is driving the need for smaller medical devices and appropriate packaging solutions to ensure safe delivery to the surgical site. Stringent regulations for medical device packaging are also playing a key role in driving demand as governments around the world implement standards to protect the safety and integrity of the devices.

Furthermore, rising awareness about the importance of proper packaging in extending the shelf life of medical devices is also driving demand.

While the adoption of medical device packaging is expected to experience significant growth, manufacturers are also facing several challenges. One of the prominent challenges is meeting stringent regulations and compliance requirements to ensure the safety and integrity of medical devices.

Another challenge is ensuring the compatibility of packaging materials with medical devices to avoid any damage. Managing costs while maintaining high standards of quality is also a significant challenge for manufacturers as they strive to produce packaging solutions at a competitive price while meeting industry standards.

Key Takeaways from the Medical Device Packaging Market:

  • The paper and paperboard market is predicted to account for USD 14,293.2 million by 2033 and to register a 5.5% CAGR throughout the projection period.
  • During the projection period, the plastic segment is expected to offer a growth potential of USD 6,620.8 million. In 2022, the boxes sector accounted for about 30% of the market. This category is also predicted to rise at a healthy 5.5% CAGR throughout the projection period.
  • Folding cartons are expected to represent an incremental potential of USD 1.9 billion over the projection period and to account for more than 21% of the market by 2033.
  • During the projection period, the medical device packaging sector in the United States is expected to exceed USD 5,067.6 million.
  • German market is predicted to provide a startling additional opportunity of USD 1,030.4 million, making it an appealing location for both investors and producers.
  • By 2033, China’s medical device packaging industry is expected to be worth USD 1,270.1 million.

Who is Winning?

Product innovation, market expansion into new markets, strategic alliances and collaborations, and acquisitions are common growth tactics employed by the industry’s leading players. Startups in the market are developing innovative technologies to efficiently label medical devices.

Packaging companies may save validation time and eventually create smaller batch sizes that comply with customer specifications by applying the same processes for identical medical devices with a few minor adjustments. The use of NFC and RFID tags in packaging materials is expected to be promoted by counterfeiting, which is a serious problem with medical supplies.

Key Players

  • Avery Dennison Corporation
  • 3M Company
  • E.I. du Pont de Nemours and Company
  • CCL Industries Inc.
  • Amcor Limited
  • Constantia Flexibles Group GmbH
  • Bemis Company, Inc
  • Sonoco Company
  • WestRock Company

Recent Developments in the Market:

  • Ashfield, a subsidiary of UDG Healthcare plc, announced the development of three business divisions in January 2021, to expand and diversify its healthcare capabilities.
  • In April 2021, Amcor presented its newest invention, the New AmSkyTM blister system. This innovation has the potential to revolutionize medical packaging sustainability.
  • In April 2020, Amcor’s ULTRA pouches was certified for steam sterilization at 134°C and vaporized hydrogen peroxide treatment. As a result, the pouches may be used to sterilize reusable medical equipment.

Medical Device Packaging Market by Category

By Material:

  • Paper and Paperboard
  • Plastics

By Packaging Format:

  • Boxes
  • Folding Cartons
  • Bags and Pouch
  • Trays
  • Inserts and Dividers
  • Wrapping Films

By End Use:

  • Surgical
  • Therapeutic
  • Diagnostic

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia and the Pacific
  • East Asia
  • The Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:     

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Consumer Electronics Packaging Market Poised for Steady Growth with 4.5% CAGR Through 2034 | Future Market Insights, Inc.

The global consumer electronics packaging market size is estimated to be around USD 19.6 billion in 2024. It is projected to exhibit a CAGR growth of 4.5% over the forecast period, with an estimated valuation of USD 30.4 billion in 2034.

With the continuous introduction of new electronic devices and gadgets, there is a constant demand for innovative packaging solutions to protect these products during transportation, storage, and display. Additionally, the growing trend of eCommerce and online retailing has fueled the need for durable and secure packaging to ensure safe delivery to consumers’ doorsteps.

Despite its growth potential, the consumer electronics packaging industry faces several challenges that act as restraints to its progress. One significant restraint is the constant pressure to reduce packaging costs while maintaining quality and functionality. This often leads to compromises in material quality and durability, which can impact the protection of electronic devices during transit.

Find Out More—Read the Complete Report for Full Insights!

A significant opportunity for players lies in the development of smart packaging solutions that integrate technology to enhance product functionality and user experience. Furthermore, the increasing adoption of sustainable packaging materials presents an opportunity for companies to align with environmental initiatives and tap into the growing market for eco-friendly solutions.

One notable trend is the increasing use of minimalist packaging designs, characterized by sleek and compact layouts that reduce material usage and environmental footprint. Another trend is the integration of smart packaging technologies, such as RFID tags and NFC chips, to enable product tracking, authentication, and interactive experiences for consumers. Moreover, there is a growing emphasis on biodegradable and compostable packaging materials, driven by consumer preferences for eco-friendly products and brands committed to sustainability.

“The rising demand for personalized and customized packaging offers opportunities for packaging manufacturers to differentiate their products and cater to the unique needs of consumers.” Says Future Market Insights (FMI).

Key Takeaways from the Market Study:

  • Corrugated boxes hold a dominant share of 23.1% in 2024, providing a cost-effective solution for manufacturers.
  • Mobile phone packaging marks its dominance with a 24.1% share in 2024.
  • The consumer electronics packaging industry in the United States is anticipated to rise at a CAGR of 2.4% through 2034.
  • The consumer electronics packaging industry in the United Kingdom is projected to rise at a CAGR of 4.6% through 2034.
  • China’s consumer electronics packaging industry is likely to witness expansion at a CAGR of 6.5% through 2034.
  • Japan’s consumer electronics packaging industry is projected to rise at a CAGR of 3.6% through 2034.
  • South Korea’s consumer electronics packaging industry is set to expand at a CAGR of 5.6% through 2034.
  • Europe & USA Consumer Electronics Packaging Market is expected to reach USD 6.4 billion by 2033, growing at a CAGR of 4.8% during the forecast period 2023 to 2033

Competitive Landscape:

The consumer electronics packaging industry includes established giants like Tetra Pak, Amcor, International Paper, and Sealed Air vie for dominance while facing increasing competition from startups. These industry players command a significant market share with their robust infrastructure and diverse offerings, yet they must contend with innovative upstarts focused on customization, sustainability, and cost efficiency.

The sector is characterized by a dynamic interplay between established players and emerging challengers, shaping the landscape with their evolving strategies and market approaches.

Sustainability is emerging as a crucial element in the consumer electronics packaging industry, driven by consumer demand and regulatory pressures. Companies are under increasing pressure to adopt eco-friendly practices and materials, with innovations in sustainability offering a competitive edge.

As the industry expands into emerging markets like China and India, companies face both opportunities and complexities. While these regions offer vast potential, navigating local regulations, preferences, and supply chains requires adaptability and a deep understanding of each industry.

Key Companies in the Market:

  • DS Smith Plc
  • Mondi Group
  • International Paper Company
  • Sonoco Products Company
  • Sealed Air Corporation
  • Huhtamaki Oyj
  • Smurfit Kappa Group PLC
  • WestRock Company
  • UFP Technologies, Inc.
  • Stora Enso Oyi
  • Pregis Corporation
  • Shenzhen Hoichow Packing Manufacturing Ltd.
  • Dordan Manufacturing Company
  • Hangzhou Xunda Packaging Co.
  • Dunapack Packaging Group
  • JJX Packaging LLC

Recent Developments:

  • Mondi Group created a novel packaging solution called PerFORMing, which is a paper-based tray that can replace plastic trays in food packing. The product is recyclable, biodegradable, and cuts plastic use by 80%.
  • Sonoco Products Company announced a new sustainability target of reducing greenhouse gas emissions by 25% by 2025. The corporation also intends to enhance its usage of renewable energy and invest in energy-efficiency initiatives.
  • Sealed Air Corporation recently introduced a new product line dubbed Korrvu Lok, a compression packaging technology that keeps items in place and minimizes damage during transportation. The solution is intended for eCommerce and omni-channel businesses, and it may minimize packaging material and labor expenses.
  • Huhtamaki Oyj acquired Jiangsu Hihio-Art Packaging Co. Ltd., a Chinese maker of paper bags, wraps, and folding carton packaging. Huhtamaki’s position in the developing foodservice packaging sector in China and Asia Pacific will be strengthened as a result of the purchase.

Key Segmentations

By Product Type:

  • Corrugated Boxes
  • Paperboard Boxes
  • Thermoformed Trays
  • Bags & Pouches
  • Blister Packs & Clamshells
  • Protective Packaging
  • Others

By Application:

  • Mobile Phones
  • Computers
    • Laptops & Tablets
    • Desktops & Servers
  • TVs, DTH & Set-Top boxes
  • Music Systems
  • Printers, Scanners & Photocopy Machines
  • Game Consoles & Toys
  • Camcorders & Cameras
  • Electronic Wearable
  • Digital Media Adapters
  • Others

By Material Type:

  • Plastic
    • Polyethylene (PE)
    • Polypropylene (PP)
    • Poly Vinyl Chloride (PVC)
    • Polyamide (PA)
    • Polyethylene terephthalate (PET)
    • Polystyrene (PS)
    • Others
  • Paper & Paperboard
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:     

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Salivary Gland Infection Treatment Market Set to Surge to USD 12,300 Million by 2033 registering a CAGR of 9.3%

The global salivary gland infection treatment market is poised for remarkable expansion, with projections indicating a surge to a valuation of USD 12,300 million by 2033. This anticipated growth represents a significant leap from the USD 5,054.79 million recorded in 2023, reflecting a robust compound annual growth rate (CAGR) of 9.3% over the forecast period, according to the latest market research report.

The optimistic outlook for the market is largely driven by the increasing prevalence of salivary gland infections worldwide. As the incidence of these infections continues to rise, the demand for effective treatment options is intensifying. Furthermore, the enhanced availability of advanced pharmaceutical interventions is contributing to the market’s growth trajectory.

Poor oral hygiene, specific underlying health conditions, and the use of certain medications have been identified as critical contributors to the heightened risk of developing salivary gland infections. This acknowledgment has spurred a significant uptick in the demand for innovative and effective treatment solutions. Healthcare providers and pharmaceutical companies are increasingly focused on developing and distributing products and services aimed at diagnosing, treating, and managing these infections efficiently.

The global salivary gland infection treatment market is at the cusp of a transformative phase, fueled by a combination of technological advancements, improved access to healthcare, and an overarching emphasis on preventive oral care. As the market continues to evolve, stakeholders across the healthcare spectrum are poised to witness substantial opportunities for growth and development in the realm of salivary gland infection treatment solutions.

Key Takeaways from the Market Study:

  • The global Salivary gland infection treatment market is expected to grow with 9.3% CAGR during 2023 to 2033.
  • By treatment, medication is expected to hold 55% of the market share in 2023 for Salivary gland infection treatment market.
  • North America is expected to possess 49% market share for Salivary gland infection treatment market in 2023.
  • Europe Salivary gland infection treatment market size is expected to possess 43% market share in 2023.

“With a growing awareness of the importance of oral health and an increasing incidence of salivary gland infections, this market is poised for continued growth and innovation in the years to come.” states an FMI analyst

Increased Market Attention: Delve into Detailed Trends and Analysis with Our Report!

Competitive Landscape:

Key players in the salivary gland infection treatment market are AbbVie Inc., Allergan, AstraZeneca, FUJIFILM Holdings Corporation, GlaxoSmithKline plc., Johnson & Johnson Services, Merck & Co., Inc., Pfizer Inc., Siemens Healthcare GmbH and Novartis AG

  • Pfizer Inc, a key player in the salivary gland infection market is focusing on investing in research and development for testing medications under clinical trials.
  • Siemens Healthcare GmbH, another key player in the salivary gland infection market is focusing on commercializing medications owing to the commonality of the ailment.

Key Segments Profiled in the Salivary Gland Infection Treatment Industry Survey:

Diagnosis:

  • MRI
  • CT Scan
  • PET Scan
  • Endoscopy
  • Biopsy

Treatment:

  • Medication
  • Surgery

Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

End Users:

  • Hospitals
  • Clinical Laboratories
  • Ambulatory Surgical Centres

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa(MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Sandhoff Disease Therapeutics Market to Witness Significant Growth, Projected to Reach USD 17.91 Million by 2033

In a recent comprehensive analysis by Future Market Insights, the global sandhoff disease therapeutics market is anticipated to undergo substantial growth over the next decade. Currently valued at USD 10 million, the market is projected to achieve a notable valuation of USD 17.91 million by 2033, reflecting a compound annual growth rate (CAGR) of 6% during the forecast period from 2023 to 2033.

Sandhoff disease, a rare genetic disorder with an incidence rate of approximately 1 in 1,000,000 individuals globally, is characterized by the accumulation of specific fats in the brain and other organs. This accumulation leads to progressive neurological damage, making the condition particularly challenging for those affected.

This significant growth in the global Sandhoff disease therapeutics market underscores the importance of innovative solutions to address the unmet medical needs of patients. As awareness about rare diseases continues to grow and advancements in medical technology expand, there is an increasing focus on developing therapies that can improve the quality of life for individuals affected by Sandhoff disease.

The findings of the analysis provide valuable insights for stakeholders in the healthcare sector, including pharmaceutical companies, research institutions, and policymakers. By understanding the evolving landscape of the Sandhoff disease therapeutics market, stakeholders can strategize and allocate resources effectively to drive innovation and enhance patient care.

Key Takeaways from the Market Study:

  • From 2018 to 2022, the Sandhoff disease therapeutics market grew at a CAGR of 4%.
  • The global Sandhoff disease therapeutics market is expected to grow with a 6% CAGR during 2023 to 2033.
  • As of 2033, the sandhoff disease therapeutics Market is expected to reach USD 17.91 Million.
  • According to the FMI analysis, hospitals account for the largest market share.
  • North America is expected to possess 40% market share for the Sandhoff Disease Therapeutics market.
  • The Asia Pacific market is predicted to increase significantly throughout the forecast period, with a share of 20%.

“A series of international level collaborations involving healthcare stakeholders across various institutional settings are fueling further clinical trials and research studies dedicated to discovering Sandhoff disease therapeutics.” says an FMI analyst

Soaring Demand for Market Information: Uncover Detailed Trends and Insights in Our Report!

Market Competition:

Key players in the market include pharmaceutical companies such as Bioasis Technologies Inc, Nuo Therapeutics Inc., Sio Gene Therapies, Inc., INTRABIO IRELAND LIMITED, Sanofi, ROIVANT SCIENCES LTD, Azafaros, Polaryx Therapeutics, Abbott Medtronic, and Merck & Co., Inc. along with healthcare providers and technology companies among other global players.

  • In November 2020, Axovant Gene Therapies Ltd., a company developing gene therapies, announced that the FDA has cleared its Investigational New Drug Application to start a registrational study of AXO-AAV-GM2 gene therapy for Tay-Sachs and Sandhoff diseases.
  • AXO-AAV-GM2 is the first gene therapy to receive IND clearance for these diseases. The FDA letter confirms that all issues related to the clinical hold have been resolved. This marks a significant moment for the GM2 gangliosidosis community and is the second IND clearance for Axovant’s gene therapy pipeline in the last year, with the first being AXO-AAV-GM1 for GM1 gangliosidosis.

More Insights Available:

FMI, in its new offering, presents an unbiased analysis of the global Sandhoff Disease Therapeutics market, presenting historical analysis from 2018 to 2022 and forecast statistics for the period of 2023 to 2033.

The study reveals essential insights on the basis of Type, Therapy, End-Users and Region.

Key Segments Profiled in the Sandhoff Disease Therapeutics Industry Survey:

Therapy:

  • Gene Therapy
  • Enzyme Replacement Therapy
  • Stem Cell Therapy

Type:

  • Acute infantile Sandhoff disease
  • Subacute juvenile Sandhoff disease
  • Late-onset Sandhoff disease

End-Users:

  • Hospitals
  • Homecare
  • Specialty Clinics

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Marking and Coding Equipment Market is Expected to Progress at a CAGR of 2.3% from 2024 to 2034 | FMI

The marking and coding equipment market is expected to be valued at USD 1,147.9 million in 2024. The progress of the market is projected to be consistent over the period from 2024 to 2034, with a CAGR of 2.3%. By 2034, the market value is forecasted to hit USD 1,455.1 million.

Marking and coding equipment demand is being propelled by the simultaneous rise of the packaging sector. The packaging industry is especially being given attention in developing countries and these countries are proving to be lucrative grounds for the marking and coding equipment market.

The increasing adoption of digital equipment is also aiding the market. Measures such as tracking products and detecting counterfeit products are helped by marking and coding equipment, further boosting their demand in the packaging sector.

Understand the Evolution: Request the Previous Source for This Report!

The marking and coding industry is benefitting from the continued progress of various end-use industries. Food and beverage is a prominent industry whose growth is immensely affecting the marking and coding equipment market. Other industries using the equipment in increasing measure include pharmaceuticals and automobiles.

High costs associated with equipment restrain the growth of the market, however. Both installation and maintenance costs of the equipment may be substantial, leading to hesitation in buying it. The risk of loss of income due to downtime of the machines is also a hindrance.

“As part of digitization trends, digital printing equipment’s demand is being bolstered. Laser printers too are rising in popularity. Thus, innovation in products is recognized as the way to go in the market,” Says Future Market Insights (FMI).

Key Takeaways from the Marking and Coding Equipment Market:

  • The marking and coding equipment market is projected to be valued at US$ 1,147.9 million in 2024.
  • Continuous inkjet printer is the prevailing technology in the market. Continuous inkjet printer is expected to account for 47.6% of the market share in 2024.
  • Food industry tops the end use segment. For 2024, food end use is anticipated to account for 43.6% of the market share.
  • India is a promising country for the market. For the forecast period, the CAGR for India is estimated to be 5.1%.
  • China is another Asian country with a bright future for the market. The CAGR for China over the forecast period is predicted to be 4.2%.
  • The market is expected to register a CAGR of 2.4% in Spain over the forecast period.

Competition Analysis of the Marking and Coding Equipment Market

Varying the product line and keeping production levels enough to meet demand are key concerns in the market. Both collaborative strategies and acquisitions are commonplace in the market. Some of the prominent companies in the market include Hitachi America, Ltd., Videojet Technologies, Inc., Markem-Imaje Corporation, and Domino Printing Sciences plc.

Key Players:

  • Hitachi America, Ltd.
  • Videojet Technologies, Inc.
  • Markem-Imaje Corporation
  • Domino Printing Sciences plc.
  • TYKMA Electrox, Inc.
  • Squid Ink Manufacturing Inc.
  • Open Date Systems, Inc.
  • MACSA ID, S.A.
  • ATD Ltd
  • RN Mark Inc.
  • Interactive Coding Equipment (ICE)
  • Diagraph Corporation
  • Linx Printing Technologies
  • Numeric Marking Systems.
  • Control Print Ltd.
  • Durable Technologies
  • REA Elektronik GmbH
  • Matthews International Corporation
  • INKJET, INC.
  • KGK Marking Technologies Group

Recent Developments in the Marking and Coding Equipment Market

  • In January 2024, the Marking Trigger Device was launched by Markem-Imaje.
  • At Pack Expo 2023, the IQJET coding and marking system was introduced by Leibinger.
  • In September 2021, the R-series was launched by Domino.

Key Segments

By Technology:

  • Continuous Inkjet (CIJ)
  • Thermal Inkjet (TIJ)
  • Thermal Transfer Overprint (TTO)
  • Laser Coding System
  • Large Character Marking (LCP)
  • Label Print Applicator (LPA)
  • Other Printers

By Application:

  • Flexible Packaging
    • Bags
    • Pouches & Sachets
    • Vacuum / Shrink films
    • Others
  • Rigid Packaging
    • Pipes & Tubes
    • Boxes
    • Bottles & Jars
    • Cans
    • Metal Parts
    • Trays & Clamshells
    • Crates
    • Others

By End Use Industry:

  • Food
  • Beverages
  • Pharmaceuticals
  • Personal & Homecare
  • Electricals & Electronics
  • Automotive
  • Chemical & Fertilizers
  • Building Materials
  • Other Industries

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:     

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Brain Tumor Drugs Market is expected to be worth USD 6.30 billion by 2033 Driven by Nanotechnology Innovations | FMI

In a groundbreaking development that offers new hope for patients battling brain tumors, the global brain tumor drugs market is on the brink of significant expansion. Recent projections highlight a robust compound annual growth rate (CAGR) of 9.2% from 2023 to 2033, with the market value anticipated to soar from USD 2.65 billion in 2023 to an impressive USD 6.30 billion by the end of 2033.

This exceptional growth trajectory is largely attributed to cutting-edge advancements in nanotechnology, which have dramatically transformed the landscape of brain tumor treatment. Nanotechnology has introduced revolutionary methods for drug delivery, enabling medications to be administered directly to cancer cells or tumors with unprecedented precision. This innovative approach not only reduces the dosage of medication required but also enhances the efficacy and extends the shelf life of treatments. Additionally, it significantly reduces toxicity levels, improving overall patient outcomes.

Nanotechnology’s impact on the brain tumor drugs market cannot be overstated. By enabling targeted drug delivery, it ensures that treatments are more effective and patients experience fewer side effects. This precision medicine approach is a significant leap forward in oncology, offering new avenues for treatment and improving the quality of life for patients suffering from brain tumors.

The projected growth in the brain tumor drugs market reflects a broader trend in medical research and pharmaceutical development, where the focus is increasingly on personalized and targeted therapies. With continued investment in nanotechnology and related fields, the future of brain tumor treatment looks promising.

Key Takeaways:

  • The brain tumor drugs market is expected to record a CAGR of 9.2% during the forecast period 2023 to 2033.
  • The primary drivers of the market are an increase in brain cancer prevalence, the presence of promising pipeline candidates, and an increased need for precision and customized treatment to drive market expansion.
  • North America dominated the brain tumor drugs market.

Key Development in the Brain Tumor Drugs Market:

  • April 2021 – MindMed and Nextage Therapeutics signed a Memorandum of Understanding (MOU) to maximize the administration of selected psychedelic drug candidates using Nextage’s unique Brain Targeting Liposome System (BTLS) delivery technology.
  • March 2021 – Roche and GenMark Diagnostics signed a comprehensive merger agreement for Roche to entirely acquire GenMark for USD 24.05 per share in an all-cash transaction.
  • September 2022 – F. Hoffmann-La Roche Ltd. announced an agreement to acquire Good Therapeutics. With this acquisition, the firm gains access to Good Therapeutic’s platform technology, which is relevant to a wide range of sectors such as cancer, autoimmune illnesses, metabolic disease, and pain management.
  • June 2022 – Novartis AG received the United States FDA approval for Tafinlar + Mekinist for the treatment of paediatric and adult patients with solid cancers containing the BRAF V600E mutation. BRAF mutations are responsible for tumor growth in over 20 different tumor types, including brain, thyroid, and others.
  • November 2021 – Pfizer Inc. purchased Trillium Therapeutics, a clinical-stage immuno-oncology startup focused on creating novel cancer medicines.

Rising Interest in Market Trends: Our Detailed Report Provides Essential Insights!

Competitive Landscape:

Prominent Participants in the Market:

  • AstraZeneca plc
  • Johnson & Johnson Inc
  • Merck & Co
  • Pfizer Inc
  • Hoffmann-La Roche Ltd
  • Y-mAbs Therapeutics, Inc
  • Shimadzu Corporation
  • Bristol-Myers Squibb
  • Bayer AG
  • Reddy’s Laboratories Ltd
  • Among others

Key Segment:

By Therapy:

  • Targeted Therapy
  • Chemotherapy
  • Immunotherapy
  • Others

By Indication:

  • Pituitary
  • Meningioma
  • Glioma
  • Others

By Distribution Channel:

  • Hospital Pharmacy
  • Retail & Online Pharmacy

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • The Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Bubble Wrap Packaging Market is Poised to Grow at a Healthy CAGR of 3.1% from 2024 to 2034 | FMI

In 2024, the bubble wrap packaging industry is expected to be valued at an impressive  US$ 3.1 billion . The bubble wrapping sector is predicted to grow rapidly and reach  US$ 4.2 billion  by 2034, exhibiting a CAGR of  3.1%  through 2034.

E-commerce and conventional hypermarkets are becoming increasingly prevalent, and the retail industry is changing dramatically. Since packaging is the initial point of contact between customers and products, it is extremely important.

Products that are damaged cause financial losses for large merchants. Bubble wrap packaging protects goods during handling and shipping, improves customer experience, and upholds brand reputation.

The e-commerce sector is expanding due to cheaper data plans and better mobile connectivity, necessitating secure packaging solutions to maintain customer loyalty in a cutthroat market.

Explore the Historical Context: Access the Old Report Source Here!

The United States eCommerce Industry Drives Sales of Bubble Wrap Packaging

The United States e-commerce industry significantly propels the demand for bubble wrap packaging due to its comfort and easy disposal. Expected to grow at a CAGR of 2.1% from 2024 to 2034, the market benefits from several key factors. The expansion of online shopping platforms has heightened the need for reliable packaging solutions to ensure product safety.

E-commerce companies invest in bubble wrap to maintain product integrity and enhance customer satisfaction. Additionally, the adoption of eco-friendly bubble wrap solutions aligns with the growing environmental consciousness among consumers and businesses, further driving demand in the United States e-commerce sector.

When it comes to shipping items, customers tend to favor bubble wrap packaging that has several key features:

  • It should be moisture-free, as this helps prevent water damage to the shipped items.
  • The packaging should be soft and flexible, providing a cushioning layer to protect against impact or jostling during transportation.
  • Bubble wrap packaging can also fill gaps within boxes or shipping containers, which can help control the temperature and prevent any shifting of the items inside.

Insulated shipping packaging is another popular option for those looking to reduce the risk of damage during transportation. This type of packaging typically contains materials that help to regulate the temperature, keeping items cool or warm as needed.

This can be especially important when shipping perishable goods, such as food or medicine. By using insulated shipping packaging, customers can have peace of mind knowing that their items are protected and are expected to arrive safely at their destination.

The bubble wrap packaging market is experiencing a surge in demand due to the global growth of eCommerce and the need for efficient packaging production and storage. Businesses increasingly turn to bubble wrap packaging for safe product transportation, particularly in the electronics sector.

This growth is driven by the need for reliable and effective solutions to ensure products arrive in excellent condition and are safe for delivery.”  says lead analyst at Future Market Insights.

Key Takeaways from the Bubble Wrap Packaging Market

  • The United States bubble wrap packaging industry is projected to experience a CAGR of 1% through 2034.
  • Japan’s bubble wrap packaging market is expected to demonstrate a rapid CAGR of 9% through 2034.
  • The United Kingdom’s bubble wrap packaging industry is anticipated to witness a CAGR of 8% through 2034.
  • The Indian bubble wrap packaging industry displays a significant CAGR of 4% through 2034.
  • The Chinese bubble wrap packaging market is expected to display a CAGR of 7% through 2034.

Competitive Landscape in the Bubble Wrap Packaging Market

The bubble wrap packaging market is undergoing significant transformation due to strategic initiatives and innovations. Market players are investing in research and development to improve performance, sustainability, and cost-effectiveness.

They are also focusing on eco-friendly alternatives made from recycled materials or biodegradable polymers. Technological advancements like automation and digital printing are driving innovation in packaging, improving production efficiency, customization, and product quality.

Companies offer customized packaging options to meet different industries and products, adding customer value. Partnerships and collaborations are being formed to expand market presence and reach new customer segments.

Emerging markets offer significant growth potential due to industrialization, urbanization, and e-commerce adoption. Market players also actively engage with customers to understand their needs and preferences, incorporating feedback into product development.

Key Companies in the Bubble Wrap Packaging Market

  • Veritiv Corporation
  • Sealed Air Corporation
  • Jiffy Packaging Co.
  • Pregis Corporation
  • Smurfit Kappa Group
  • Barton Jones Packaging Ltd.
  • IVEX Protective Packaging Inc
  • Automated Packaging System
  • Storopack Hans Reichenecker GmbH
  • Flexi-Hex
  • Atlantic Packaging Products Ltd.
  • Signode Industrial Group
  • Kaneka Corporation

Recent Developments in the Bubble Wrap Packaging Industry

  • Go Do Good Studio, a material innovation startup located in Pune, India, created a flexible film with a range of packaging in September 2023, using algae collected from India’s coastal regions.
  • Ranpak introduced the Wrap ‘n Go converter, an easy-to-use, retail-grade protective honeycomb paper with a self-adjusting tensioning mechanism for smoothness, in August 2023 in North America.

Bubble Wrap Packaging Market: Key Segmentations

By Product Type:

  • Bubble Sheets
  • Bubble Bags and mailers

By Material:

  • LDPE
  • HDPE
  • LLDPE

By End Use:

  • Manufacturing & Warehousing
    • Pharmaceuticals
    • Electronics & Electricals
    • Automotive & Allied Industries
    • Food & Beverages
    • Cosmetics & Personal Care
    • Others (Agriculture, Healthcare, etc.)
  • e-Commerce
  • Logistics & Transportation

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:     

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Rosai-Dorfman Disease (RDD) Therapeutics Market to Reach USD 839.95 Million by 2033, Fueled by Rising Prevalence and Innovation in Treatment Approaches | FMI

The global rosai-dorfman disease (RDD) therapeutics market is poised for significant growth, with projections indicating an increase from USD 431 Million in 2023 to USD 839.95 Million by 2033, reflecting a robust CAGR of 6.9% during the forecast period. This surge is attributed to the rising prevalence of RDD, an increasing demand for effective therapeutic solutions, and advancements in novel treatment pipelines.

Key Market Drivers:

  1. Rising Prevalence of RDD: The incidence of Rosai-Dorfman Disease, a rare histiocytic disorder, continues to grow globally, necessitating the development of targeted therapies.
  2. Demand for Effective Treatments: Patients and healthcare providers are increasingly seeking effective treatment options, driving the development and adoption of innovative therapeutic solutions.
  3. Advances in Novel Therapies: The growing pipeline of RDD-specific treatments, backed by substantial investments in research and development, is a critical driver of market expansion.

Historical Performance and Future Outlook:

During the historical period from 2018 to 2022, the market demonstrated a CAGR of 3.3%, showcasing steady growth. However, the upcoming decade is set to witness a significant acceleration in market dynamics, driven by advancements in drug development, strategic collaborations, and increased awareness of rare diseases.

Industry Insights:

Key players in the Rosai-Dorfman Disease Therapeutics market are focused on developing groundbreaking treatments and improving patient outcomes. With growing support from regulatory bodies and increased funding for rare disease research, the market is poised for transformational growth in the coming years.

The Rosai-Dorfman Disease Therapeutics market represents a promising avenue for investment and innovation. As the prevalence of this rare disorder continues to rise, the industry is set to play a crucial role in addressing unmet medical needs and enhancing the quality of life for patients worldwide.

Key Takeaways from the Market Study:

  • The Rosai-Dorfman Disease (RDD) Therapeutics market is expected to grow at a value of 6.9% CAGR in the forecast period 2023-2033
  • By distribution channel, hospital pharmacies are expected to possess 46% market share for Rosai-Dorfman Disease (RDD) Therapeutics market in 2023.
  • North America is expected to possess 40% market share for Rosai-Dorfman Disease (RDD) Therapeutics market in 2023.
  • Asia Pacific is expected to possess 35% market share for Rosai-Dorfman Disease (RDD) Therapeutics market in 2023.

“Development of targeted therapeutics and personalized medicine is expected to provide significant growth opportunities in the coming years.” states an FMI analyst

Increased Market Demand: Get In-Depth Analysis and Insights with Our Complete Report!

Competitive Landscape:

Key players in the Rosai-Dorfman Disease (RDD) Therapeutics market are Teva Pharmaceuticals Ltd., Zydus Pharmaceuticals, Inc., Sun Pharmaceuticals Industries Ltd, Advanz Pharmaceticals, Novartis AG, Mylan N.V., Aurobindo Pharma, Dr. Reddy’s Laboratories Ltd, Viatris Inc., Pfizer Inc.

  • Teva Pharmaceuticals Ltd, a key player in the Rosai-Dorfman Disease (RDD) Therapeutics market is focusing on investing in research and development to innovate medication for treating the ailment.
  • Zydus Pharmaceuticals, Inc, another key player in the Rosai-Dorfman Disease (RDD) Therapeutics market is focusing on integrating technology to understand the nature of the ailment and innovate medication for early-stage treatment.

Key Segments Profiled in the Rosai-Dorfman Disease (RDD) Therapeutics Industry Survey:

Drug Class:

  • MEK-inhibitors
    • Cobimetinib
    • Trametinib
    • Binimetinib
  • Immunosuppressants and modulators
    • Mercaptopurine
    • Azathioprine
    • Lenalidomide
    • Thalidomide
  • Chemotherapy
    • Cladribine
    • Cytarabine
    • Vinblastine
    • Hydroxyurea
    • Methotrexate

Treatment:

  • PET Scan
  • CT scan
  • MRI
  • Ultrasounds
  • Blood Tests

End User:

  • Hospitals
  • Clinical Laboratories

Distribution Channel:

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa(MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Progressive Multifocal Leukoencephalopathy Treatment Market to reach USD 1,773.97 Million by 2033, growing at a 3% CAGR: FMI Report

The global progressive multifocal leukoencephalopathy treatment market is expected to garner a market value of USD 1,320 million in 2023 and is expected to accumulate a market value of USD 1,773.97 million by registering a CAGR of 3% in the forecast period 2023 to 2033. The market for progressive multifocal leukoencephalopathy treatment registered a CAGR of 2% in the historical period 2018 to 2022.

According to the latest studies, PML occurs in approximately one in 200,000 people. As per the same report, each year, it is estimated that 4,000 people develop PML in the United States and Europe combined. The increasing demand for these treatments is expected to lead to the development of new and innovative treatments, which will drive the growth of the market in the coming years.

North America is anticipated to acquire a market share of about 40% in the forecast period. This growth is attributed to the rising prevalence of the condition in the region. Furthermore, government initiatives and increase in the number of research partnerships are boosting the market growth across North America.  Asia Pacific is a growing market due to a shift towards point-of-care healthcare. The increasing number of hospitals in India and China presents a promising market opportunity globally.

Key Takeaways from the Market Study:

  • From 2018 to 2022, the Progressive Multifocal Leukoencephalopathy Treatment market grew at a CAGR of 2%.
  • The global Progressive Multifocal Leukoencephalopathy Treatment market is expected to grow with a 3% CAGR during 2023 to 2033.
  • As of 2033, the Progressive Multifocal Leukoencephalopathy Treatment Market is expected to reach USD 1773.97 Million.
  • According to the FMI analysis, hospital pharmacies account for the largest market share.
  • North America is expected to possess 40% market share for the Progressive Multifocal Leukoencephalopathy Treatment market.
  • The South and East Asia market is predicted to increase significantly throughout the forecast period, with a share of 20% during the forecast period.

“A series of international level collaborations involving healthcare stakeholders across various institutional settings are fueling further clinical trials and research studies dedicated to discovering progressive multifocal leukoencephalopathy treatment.” says an FMI analyst

High Demand for Market Insights: Discover Comprehensive Trends in Our Full Report!

Market Competition:

Key players in the market include pharmaceutical companies such as NeoImmuneTech, Neurimmune, GlaxoSmithKline Plc, Sanofi S.A., Gilead Sciences, Inc., Allergan Plc., Novartis AG, AbbVie Inc., and Bristol-Myers Squibb Company along with healthcare providers and technology companies among other global players.

  • In October 2022, Cellevolve Bio, Inc., a company focused on developing and commercializing cell therapies, announced that its Investigational New Drug (IND) application for CE-VST01-JC has been approved by the U.S. Food and Drug Administration (FDA). CE-VST01-JC is a JC Virus Specific T Cell Therapy that is being studied for the treatment of progressive multifocal leukoencephalopathy (PML) and has received orphan drug designation from the FDA.
  • The safety and effectiveness of CE-VST01-JC will be tested in a global, multi-center, randomized, double-blind, placebo-controlled Phase 2 study called ASCEND-JC. The study is expected to enroll up to 60 patients across the US, Canada, and EU, with the first patient enrollment anticipated in the first half of 2023.

Key Segments Profiled in the Progressive Multifocal Leukoencephalopathy Treatment Industry Survey

Treatment:

  • Anti-retroviral Therapy
  • Antiviral/Anti JCV
  • Other Symptomatic

Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Indication:

  • HIV/AIDS
  • Organ Transplantation
  • Multiple Sclerosis
  • Hematologic Malignancies

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Active, Smart, and Intelligent Packaging Market is Growing at a Strong CAGR of 8.3% from 2024 to 2034 | FMI

The global active, smart, and intelligent packaging market is poised for remarkable expansion, with an estimated valuation of USD 26.6 billion in 2024 and projected to reach USD 59.1 billion by 2034. This growth represents a compound annual growth rate (CAGR) of 8.3% over the forecast period from 2024 to 2034.

Core Concepts in the Active, Smart, and Intelligent Packaging Industry

  • Current Market Size (2024): Estimated at US$ 26.6 billion.
  • Growth Outlook: The market is expected to grow at a CAGR of 8.3% during the forecast period.
  • Projected Value by 2034: Predicted to reach US$ 59.1 billion.
  • Historical Market Size (2019): Valued at US$ 19.4 billion.
  • Regional Growth Potential: China is anticipated to experience the highest growth with a CAGR of 9.7% through 2034.

Backtrack for Better Insights: Access the Old Source of This Report Here!

Key Market Trends and Insights:

  1. Dominance of Active Packaging: Active packaging is anticipated to continue dominating the market, holding a substantial three-fourths of the market share in 2024. This segment’s growth is driven by its ability to enhance product preservation and safety, making it the preferred choice across various industries.
  2. Significant Applications in Food & Beverage: The food and beverage sector remains the largest consumer of active, smart, and intelligent packaging solutions, accounting for nearly half of the total market share in 2024. The surge in consumer demand for transparency and freshness in food products is fueling the adoption of advanced packaging technologies, including RFID and other emerging innovations.
  3. Technological Innovations Enhance Consumer Experience: The integration of technologies such as Near-field Communication (NFC) and augmented reality is revolutionizing packaging. For example, La Roche Posay’s My UV Patch by L’Oreal exemplifies how NFC and custom mobile applications can provide personalized consumer experiences, reflecting the growing trend of tailored solutions.
  4. Historical Performance and Future Outlook: The market, valued at USD 19.4 billion in 2019, saw a growth rate of 4.8% from 2019 to 2023, reaching approximately USD 24.6 billion by the end of 2023. Despite a downturn in 2020 and 2021, the market rebounded strongly in response to heightened demand for pharmaceutical packaging during the pandemic.

Driving Factors Behind Market Growth:

  • Rising Income and Urbanization: Increasing global income levels and rapid urbanization are shifting consumer preferences towards packaged food and beverages. This trend, coupled with the rise of modern retail and e-commerce, is creating a fertile environment for the growth of active, smart, and intelligent packaging solutions.
  • Extended Shelf Life Demand: The growing demand for products with extended shelf life is a key factor driving market growth. Consumers’ desire for fresh, long-lasting products is accelerating the adoption of advanced packaging technologies.

Regional Market Highlights:

  • United States: The U.S. market for active, smart, and intelligent packaging is forecasted to grow at a CAGR of 7.9% through 2034. The presence of leading manufacturers and the launch of innovative packaging solutions are expected to drive growth in the region.
  • United Kingdom: In the U.K., the market is projected to advance at a rate of 7.1% over the next decade. Increased adoption of active packaging by food and beverage manufacturers, along with significant R&D investments in sensor-based packaging, will propel the market forward.

Competitive Landscape

Globally recognized makers of active, smart, and intelligent packaging are looking to form strategic alliances with major end-use sectors. They are also working on developing creative packaging to meet today’s packaging needs. Furthermore, the packaging with sensors market is predicted to become more competitive as domestic and foreign manufacturers continue to innovate their products.

Key Players

  • PakSense, Inc.
  • Landec Corporation
  • Sealed Air Corporation
  • Crown Holdings, Inc.
  • Amcor Plc
  • 3M Company
  • Timestrip UK Ltd.
  • Cryolog S.A.
  • Vitsab International AB
  • Varcode, Ltd.
  • LCR Hallcrest LLC
  • Thin Film Electronics ASA
  • CCL Industries Inc.
  • Temptime Corporation
  • Multisorb Technologies, Inc.
  • Coveris Holdings S.A.

Recent Developments in the Global Active, Smart, and Intelligent Packaging Market

  • In March 2022, Varcode Ltd. partnered with General Data Company, Inc., a leading provider and manufacturer of barcode identification, labeling, packaging, data management, and equipment service products and solutions.
  • In May 2021, Varcode Ltd. announced an agreement with Media Sourcery, Inc. to integrate its Smart Tag™ technology into cold chain solutions.
  • In March 2021, Amcor announced a collaboration with JD Farm to jointly launch NFC (near field communication)-enabled packaging that will ensure more effective and interactive consumer engagement.

Key Segments Covered by Active, Smart, and Intelligent Packaging Industry Survey Report

By Packaging Type:

  • Active Packaging
    • Oxygen Scavenging Sachets
    • Modified Atmosphere Packaging (MAP)
  • Smart & Intelligent Packaging
    • Time & Temperature Indicator (TTI) Labels
    • Freshness Indicators
    • Radio Frequency Identification (RFID) Tags

By Application:

  • Food & Beverage
    • Meat, Poultry & Seafood
    • Fruits & Vegetables
    • Dairy Products
    • Bakery & Confectionary
    • Processed Food
    • Others
  • Pharmaceuticals
  • Cosmetics
  • Other Applications

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia and Pacific
  • Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:     

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube